Pacific Biosciences of California PACB
$ 1.79
3.78%
Quarterly report 2024-Q1
added 05-09-2024
Country |
USA |
IPO year |
2010 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Michael Hunkapiller |
Employees in the company |
404 |
Shares |
254 M |
Market Cap[1] |
$ 454 M |
EBITDA (LTM) |
$ -298 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.